(Q54362641)

English

Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

Combined analysis of levels of serum B-cell activating factor and a proliferation-inducing ligand as predictor of disease progression in patients with chronic lymphocytic leukemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

0 references

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

6

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

7

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

8

object named as

Marta Aymerich

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

Emili Montserrat

10

object named as

Emili Montserrat

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

author name string

Gerardo Ferrer

1

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

Kate Hodgson

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

Arturo Pereira

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

Montse Elena

5

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

Tycho Baumann

9

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

Carol Moreno

11

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

publication date

27 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

52

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

11

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

2064-2068

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

BAFF AND APRIL: a tutorial on B cell survival

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

BAFF, APRIL and human B cell disorders

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Sonic hedgehog mRNA expression by real-time quantitative PCR in normal and tumor tissues from colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

The microenvironment in mature B-cell malignancies: a target for new treatment strategies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.591008

21 January 2018

Identifiers

10.3109/10428194.2011.591008

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

release_ibx43rtgs5echpvtxs4agt44hi

1 reference

https://api.fatcat.wiki/v0/release/ibx43rtgs5echpvtxs4agt44hi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21707303

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54362641&oldid=1976448245"